Hian Fook Voon

Hian Fook Voon

Director/Board Member at DLC ASIA LIMITED
60 year
Finance
Consumer Services
Commercial Services

Profile

Currently, Hian Fook Voon is Chief Executive Officer at Labyrx Immunologic Therapeutics Ltd. since 2018, Vice Chairman at TransAsia Private Capital Ltd. since 2013, Chairman at Oski Capital Partners Ltd. since 2015, Vice Chairman at The Manhasset Bay Group, Inc. since 2013, Independent Non-Executive Director at DLC Asia Ltd. since 2018, and Member of the American Bar Association since 1991.
Formerly, Mr. Voon was Independent Non-Executive Director at HKC (Holdings) Ltd., Associate at Shearman & Sterling LLP from 1991 to 1993, and Partner at Goldman Sachs LLC from 2004 to 2011.
Education includes a graduate degree from Harvard University conferred in 1991 and an undergraduate degree from the University of California, Berkeley conferred in 1988.

Hian Fook Voon active positions

CompaniesPositionStart
DLC ASIA LIMITED Director/Board Member 30/07/2018
Oski Capital Partners Ltd.
Chairman 01/08/2015
Director/Board Member 01/03/2013
Director/Board Member 01/04/2013
Corporate Officer/Principal 01/01/1991
Chief Executive Officer 01/07/2018

Former positions of Hian Fook Voon

CompaniesPositionEnd
Goldman Sachs LLC
Corporate Officer/Principal 01/01/2011
Corporate Officer/Principal 01/11/1993
HKC (HOLDINGS) LIMITED Director/Board Member -
See the detail of Hian Fook Voon's experience

Training of Hian Fook Voon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Consumer Services

Commercial Services

Consumer Services

Commercial Services

Finance

Goldman Sachs LLC

Finance

Finance

Oski Capital Partners Ltd.

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Hian Fook Voon